Article info

Download PDFPDF

315 ERAS leads to fewer hospital costs in advanced ovarian cancer surgery: a secondary outcome of the PROFAST trial
Free

Authors

Citation

Bebia Conesa V, Rodríguez Conde S, Asuncion P, et al
315 ERAS leads to fewer hospital costs in advanced ovarian cancer surgery: a secondary outcome of the PROFAST trial

Publication history

  • First published October 12, 2021.
Online issue publication 
October 12, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.